
Biogen is looking for a new CEO less than a year after the launch of its Alzheimer’s drug largely fizzled.
The company said Tuesday that current CEO Michel Vounatsos will continue to lead the company until a successor is found.

Biogen is looking for a new CEO less than a year after the launch of its Alzheimer’s drug largely fizzled.
The company said Tuesday that current CEO Michel Vounatsos will continue to lead the company until a successor is found.